Steven Cummings is a Technical Specialist with the firm, where he assists with the prosecution of patent applications in a wide range of subject matters, including chemistry, chemical engineering, biotechnology, and pharmaceuticals.
Prior to transitioning to the intellectual property field, Steven received his Ph.D. in Chemical Engineering from The Ohio State University. He conducted his dissertation research at the National Institutes of Health in the National Institute of Neurological Disorders and Stroke. His dissertation research was directed to the characterization of post-translational modifications in the microtubule cytoskeleton using a variety of tools, including TIRF microscopy, mass spectrometry, and in vitro reconstitution assays. He earned a Bachelor of Engineering in Chemical Engineering from McGill University.
Zhuang, Z, Cummings SW (co-first author), Roll-Mecak A, Tanner ME (2022). “Phosphinic acid-based inhibitors of tubulin polyglycylation.” <em>Chemical Communications</em> 58(45):6530-6533.
Szczesna E, Zehr E, Cummings SW, Szyk A, Mahalingan K, Li Y, Roll-Mecak A (2022). “Combinatorial and antagonistic effects of tubulin glutamylation and glycylation on katanin microtubule severing.” <em>Developmental Cell</em> 57(21):2497-2513.
Daley EL, Sarbanes SL, Cummings SW, Roll-Mecak A (2023). “The tubulin code, from molecules to health and disease.” <em>Annual Review of Cell and Developmental Biology</em> 39:331-361.
Cummings SW, Li Y, Spector JO, Kim C, Roll-Mecak A (2024). “The polyglycylase TTLL10 is stimulated by tubulin glutamylation and progressively inhibited by polyglyclation.” <em>eLife.</em>